Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

385
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
385

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Implementing a Multi-Ancestry Polygenic Risk Score for Coronary Heart Disease in a Diverse Cohort.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

21-Hydroxylase Deficient Congenital Adrenal Hyperplasia Due to Maternal Uniparental Isodisomy.

Case reports in endocrinology·2026
Same author

Rapid germ line testing with hair root bulb-derived DNA for hereditary predisposition and inherited marrow failure states.

Blood advances·2026
Same author

Composite Phenotype: Recurrent Nephrolithiasis and Chronic Kidney Disease in an Adult with Biallelic <italic>SLC34A3</italic> and Monoallelic <italic>SLC3A1</italic> Pathogenic Variants - Who Is "The Culprit"?

Kidney & blood pressure research·2026
Same author

DPYD Sequencing Identifies More Clinically Relevant Variants as Compared to Targeted Genotyping.

Clinical chemistry·2026
Same author

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update.

Clinical pharmacology and therapeutics·2026

相关实验视频

Updated: Sep 12, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K

基于EHR的CDS工具支持药物基因组学的长期实施.

Pedro J Caraballo1, Jessica A Wright2, Joseph A Sutton3

  • 1Department of Medicine, Mayo Clinic, Rochester, MN, USA.

Studies in health technology and informatics
|August 8, 2025
PubMed
概括

药物基因组学 (PGx) 改善了处方. 一个多学科计划实施了PGx-临床决策支持 (CDS) 对42,000名患者的45种药物基因相互作用,成功触发了9000多项干预.

关键词:
临床决策支持 临床决策支持决策是做出决策的过程.电子健康记录 电子健康记录个性化医疗是个性化的医疗.药物基因组学 药物基因组学

更多相关视频

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

500
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.7K

相关实验视频

Last Updated: Sep 12, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

500
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.7K

科学领域:

  • 临床药理学 临床药理学
  • 遗传学和基因组学 遗传学和基因组学
  • 医疗信息学 医疗信息学

背景情况:

  • 药物基因组学 (PGx) 提供了优化药物处方的潜力.
  • 临床决策支持 (CDS) 系统可以将PGx数据集成到电子健康记录中.
  • 实施PGx-CDS需要多学科的方法和强大的基础设施.

研究的目的:

  • 描述一个多学科的药物基因组学临床决策支持 (PGx-CDS) 计划的实施和结果.
  • 评估PGx-CDS对大量患者队列的临床实践的影响.

主要方法:

  • 开发一个多学科的计划,从2012年开始实施PGx-CDS.
  • 整合了45种药物基因相互作用的PGx测试结果.
  • 在42,000名患者的电子健康记录中全系统实施PGx-CDS.

主要成果:

  • 实施了PGx-CDS,涵盖了45种药物基因相互作用.
  • 纳入了42,000名PGx测试结果的患者的数据.
  • 在2023年处方时,约有9,281次CDS干预被触发.

结论:

  • 多学科的PGx-CDS计划已经成功实施.
  • 触发干预的高数量表明对处方实践产生了重大影响.
  • 该计划展示了将PGx整合到常规临床护理中的可行性和成功.